Get notified when SPRB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSpruce Biosciences reports $107.3M cash position and Q1 2026 results
Filed May 13, 2026 · Period ending May 13, 2026 · ~1 min read
Key Changes
-
high
Company disclosed preliminary cash and cash equivalents of $107.3 million as of April 30, 2026, though this figure is unaudited and subject to change upon completion of financial closing procedures.
Item 8.01 view on EDGAR → -
medium
Spruce announced financial results for the first quarter ended March 31, 2026 via press release, though specific revenue and earnings metrics were not disclosed in the 8-K filing body.
Item 8.01 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade SPRB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify